|Bid||0.0000 x 1400|
|Ask||0.0000 x 3000|
|Day's range||0.7699 - 0.8500|
|52-week range||0.6300 - 8.1000|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||15 May 2023 - 19 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
CHICAGO, March 27, 2023--Exicure, Inc., reported financial results for the year ended December 31, 2022 and provided an update on its business strategy and corporate progress.
CHICAGO, February 24, 2023--Exicure today announced the closing of the previously-announced private placement transaction with CBI USA, Inc. effective February 24, 2023.
CHICAGO, December 14, 2022--Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements